There are 2789 resources available
1503O - Clinical and scientific impact of National Cancer Institute: Sponsored clinical trial network group treatment trials
Presenter: Joseph Unger
Session: Proffered Paper session - Public policy
Resources:
Abstract
Slides
Webcast
1504O - Anti-cancer drug price regulation in India: Financial implications and annual savings to patients
Presenter: Krishnamani Kalpathi
Session: Proffered Paper session - Public policy
Resources:
Abstract
Slides
Webcast
833O - A phase Ib study result of HMPL-689, a PI3Kδ inhibitor, in Chinese patients with relapsed/refractory lymphoma
Presenter: Junning Cao
Session: Proffered Paper session - Haematological malignancies
Resources:
Abstract
Slides
Webcast
Introduction by the chair
Presenter: Samra Turajlic
Session: Patient-derived cancer models to inform clinical decision making: More merits or more limitations?
Resources:
Slides
Webcast
More merits
Presenter: Nicola Valeri
Session: Patient-derived cancer models to inform clinical decision making: More merits or more limitations?
Resources:
Slides
Webcast
More limitations
Presenter: Livio Trusolino
Session: Patient-derived cancer models to inform clinical decision making: More merits or more limitations?
Resources:
Slides
Webcast
Polling 2 (led by chair)
Presenter: Samra Turajlic
Session: Patient-derived cancer models to inform clinical decision making: More merits or more limitations?
Resources:
Slides
Webcast
Q&A
Presenter: Samra Turajlic
Session: Patient-derived cancer models to inform clinical decision making: More merits or more limitations?
Resources:
Slides
Invited Discussant 567O_PR
Presenter: Rocio Garcia-Carbonero
Session: Presidential symposium 3
Resources:
Slides
Webcast
Invited Discussant 1557O and LBA8
Presenter: Marie von Lilienfeld-Toal
Session: Presidential symposium 3
Resources:
Slides
Webcast